US President Donald Trump has “warned” India of retaliation if it doesn’t export it hydroxychloroquine, which is a key anti-malaria drug used in the treatment of coronavirus. This comes after India banned the export of the drug while experts test its efficacy in helping treat COVID-19 patients.
“I would be surprised if he would, you know, because India does very well with the United States,” Mr Trump told reporters during a press briefing at the White House on Monday.
“So, I would be surprised if that were his (Prime Minister Narendra Modi’s) decision. He’d have to tell me that. I spoke to him Sunday morning, called him, and I said we’d appreciate your allowing our supply to come out. If he doesn’t allow it to come out, that would be okay, but of course there may be retaliation. Why wouldn’t there be?” the US President was quoted as saying by news agency PTI.
Also Read: 14 Times Large Pink Super Moon To Appear On This Day, Get Your Cameras Ready Guys
Notably, India is the largest manufacturer of medicine and has been using the drug for treating the health care staff. India, which is seeing over 500+ new cases every day, has also banned the export of ventilators, sensitisers, testing kit, masks, etc.
However, the Indian government has also said that though it has banned the export, it may allow it on a “case-to-case basis” on humanitarian grounds.
Amid rising pressure from the US and the world, India today might take the decision of supplying the drug. India will separate enough stock for the country before exporting the same as per a report by NDTV.
Also Read: 9Baaje9Minute: Ghost Guy Walks Around With Candle & ‘Gumnaam Hai Koi’ Playing In Background
America is an urgent need of the drug as it has reported a whopping rise in the coronavirus cases in the last few weeks. The positive cases in the country stand at 3,66,000+ with over 10,000 deaths.
